These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7472779)

  • 1. Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis.
    Lipponen P; Pietiläinen T; Kosma VM; Aaltomaa S; Eskelinen M; Syrjänen K
    J Pathol; 1995 Sep; 177(1):49-55. PubMed ID: 7472779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53 protein has no independent prognostic value in breast cancer.
    Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
    J Pathol; 1995 Nov; 177(3):225-32. PubMed ID: 8551383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 protein expression and long-term survival in breast cancer.
    Joensuu H; Pylkkänen L; Toikkanen S
    Am J Pathol; 1994 Nov; 145(5):1191-8. PubMed ID: 7977649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer.
    Lipponen P; Saarelainen E; Ji H; Aaltomaa S; Syrjänen K
    J Pathol; 1994 Oct; 174(2):101-9. PubMed ID: 7965405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival.
    Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
    Anticancer Res; 1995; 15(3):959-64. PubMed ID: 7645986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. bcl-2 and apoptosis in lymph node positive breast carcinoma.
    Berardo MD; Elledge RM; de Moor C; Clark GM; Osborne CK; Allred DC
    Cancer; 1998 Apr; 82(7):1296-302. PubMed ID: 9529021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
    Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S
    J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers.
    Zhang GJ; Kimijima I; Abe R; Watanabe T; Kanno M; Hara K; Tsuchiya A
    Anticancer Res; 1998; 18(3B):1989-98. PubMed ID: 9677455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis.
    Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C
    Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
    Huang J; Tan PH; Thiyagarajan J; Bay BH
    Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
    Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC
    Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
    Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
    Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.
    Rakha EA; Pinder SE; Paish EC; Robertson JF; Ellis IO
    J Pathol; 2004 Jul; 203(3):754-61. PubMed ID: 15221934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.
    Sinicrope FA; Hart J; Michelassi F; Lee JJ
    Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients.
    Kapranos N; Karaiosifidi H; Valavanis C; Kouri E; Vasilaros S
    Anticancer Res; 1997; 17(4A):2499-505. PubMed ID: 9252670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.